Moonlake Immunotherapeutics (MLTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MLTX | AMGN | VRTX | BMY | GILD |
| Company | Moonlake Immunotherapeutics | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 52.29 | 262.21 | 407.20 | 57.66 | 93.17 |
| High | 55.84 | 264.73 | 410.82 | 57.88 | 94.25 |
| Low | 52.29 | 261.76 | 406.02 | 57.51 | 92.98 |
| Last | 54.51 | 263.54 | 408.59 | 57.68 | 94.02 |
| Change | +1.84 | -0.95 | +0.41 | -0.08 | +0.07 |
| % Change | +3.49% | -0.36% | +0.10% | -0.14% | +0.07% |
| Volume | 99,355 | 684,017 | 602,044 | 1,846,620 | 1,285,801 |
| 20-Day Average Volume | 175,401 | 4,182,567 | 1,794,930 | 11,107,881 | 7,012,060 |
| Previous Close | 52.67 | 264.49 | 408.18 | 57.76 | 93.95 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 53.37 | 271.21 | 449.13 | 57.81 | 92.44 |
| 20-Day Raw Stochastic | 65.34% | 35.15% | 32.25% | 51.80% | 90.73% |
| 20-Day Relative Strength | 56.38% | 33.15% | 34.63% | 53.58% | 58.62% |
| Weighted Alpha | +3.85 | -14.83 | -7.43 | +20.21 | +26.44 |
| Today's Opinion | 100% Buy | 88% Sell | 72% Sell | 80% Buy | 100% Buy |
| Previous Opinion | 88% Buy | 88% Sell | 72% Sell | 80% Buy | 100% Buy |
| Last Month's Opinion | 88% Buy | 72% Sell | 8% Sell | 100% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.16% since 12/18/24 | +2.00% since 12/18/24 | -8.46% since 12/18/24 | +1.43% since 12/18/24 | +3.80% since 12/18/24 |
| Low | 50.21 on 12/20/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 56.08 on 12/20/24 | 90.27 on 12/19/24 |
| High | 55.84 on 12/26/24 | 269.61 on 12/20/24 | 410.82 on 12/26/24 | 57.88 on 12/26/24 | 94.25 on 12/26/24 |
| 1-Month | |||||
| %Chg | +4.98% since 11/26/24 | -5.73% since 11/26/24 | -12.29% since 11/26/24 | -1.85% since 11/26/24 | +3.05% since 11/26/24 |
| Low | 50.21 on 12/20/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 55.04 on 12/13/24 | 89.15 on 12/13/24 |
| High | 58.26 on 12/17/24 | 283.64 on 11/29/24 | 476.46 on 12/10/24 | 60.09 on 12/03/24 | 94.65 on 12/11/24 |
| 3-Month | |||||
| %Chg | +7.98% since 09/26/24 | -17.28% since 09/26/24 | -11.55% since 09/26/24 | +15.03% since 09/26/24 | +13.37% since 09/26/24 |
| Low | 45.24 on 10/31/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 50.71 on 09/27/24 | 82.82 on 10/01/24 |
| High | 58.26 on 12/17/24 | 329.17 on 10/11/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +38.02% since 06/26/24 | -15.62% since 06/26/24 | -13.58% since 06/26/24 | +35.66% since 06/26/24 | +35.82% since 06/26/24 |
| Low | 39.36 on 08/02/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 39.35 on 07/05/24 | 66.01 on 07/05/24 |
| High | 58.26 on 12/17/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,365,876 | 142,172,096 | 105,118,176 | 117,147,504 | 117,086,688 |
| Shares Outstanding, K | 63,905 | 537,533 | 257,529 | 2,028,177 | 1,246,266 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -36,010,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -35,390,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 1.31 | 0.55 | 0.36 | 0.45 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.56 on 11/07/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/12/24 | 02/04/25 | 02/03/25 | 02/06/25 | 02/11/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.600 on 10/04/24 | 0.770 on 12/13/24 |
| Next Ex-Dividends Date | N/A | 02/14/25 | N/A | 01/03/25 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.74 | 0.00 | 49.21 | 21.08 |